The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...